The AT1 inhibitor losartan exerted potent preventive and restorative effects on Alzheimer’s Disease hallmarks, possibly by mitigating AT1-initiated oxidative stress (Ongali et al., 2014). The gene discussed is AGTR1; the disease is early-onset autosomal dominant Alzheimer disease.